Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Isoniazid
Drug ID BADD_D01204
Description Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Indications and Usage For the treatment of all forms of tuberculosis in which organisms are susceptible.
Marketing Status Prescription; Discontinued
ATC Code J04AC01
DrugBank ID DB00951
KEGG ID D00346
MeSH ID D007538
PubChem ID 3767
TTD Drug ID D09XQF
NDC Product Code 71610-108; 50090-1490; 60687-553; 43063-463; 71052-611; 50090-0370; 12785-0002; 50090-0410; 0527-1109; 53002-2920; 71335-0275; 68788-9405; 71610-395; 0555-0071; 46287-009; 63187-978; 12785-0003; 66639-914; 0781-3056; 0555-0066; 70518-0096; 70518-2576; 51079-083
Synonyms Isoniazid | Isonicotinic Acid Hydrazide | Hydrazide, Isonicotinic Acid | Phthivazide | Phthivazid | Isonicotinic Acid Vanillylidenehydrazide | Acid Vanillylidenehydrazide, Isonicotinic | Vanillylidenehydrazide, Isonicotinic Acid | Ftivazide | Tubazide | Isonex
Chemical Information
Molecular Formula C6H7N3O
CAS Registry Number 54-85-3
SMILES C1=CN=CC=C1C(=O)NN
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HepatotoxicityN-alpha-acetyltransferase 20P61599Not Available3691615; 9922980
HepatotoxicityOmega-amidase NIT2Q9JHW2Not Available26004706
HepatotoxicityGlutathione peroxidase 1P04041Not Available26004706
HepatotoxicityAlanine aminotransferase 1P24298Not Available4000989; 707874; 110184
HepatotoxicityN-alpha-acetyltransferase 20P61599Not AvailableNot Available
HepatotoxicityAlbuminP02770Not Available26004706
HepatotoxicityCatalaseP04762Not Available26004706
Systemic lupus erythematosusN-alpha-acetyltransferase 20P61599Not AvailableNot Available
Systemic lupus erythematosusN-alpha-acetyltransferase 20P61599Not Available3691615; 9922980
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Azotaemia20.01.01.0010.019111%Not Available
Bilirubin conjugated increased13.03.01.0070.019111%Not Available
Bilirubinuria20.02.01.015--Not Available
Blindness17.17.01.003; 06.02.02.0010.012741%Not Available
Blister23.03.01.001; 12.01.06.0020.019111%Not Available
Blood bilirubin increased13.03.01.0080.038222%
Blood chloride increased13.11.01.0050.012741%Not Available
Blood creatine phosphokinase increased13.04.01.0010.031851%
Blood creatinine increased13.13.01.0040.031851%
Blood glucose increased13.02.02.0020.019111%Not Available
Blood lactate dehydrogenase increased13.04.02.0020.012741%
Blood pressure decreased13.14.03.0020.012741%Not Available
Blood pressure increased13.14.03.005--Not Available
Blood urea increased13.13.01.0060.025481%Not Available
Blood uric acid13.02.04.003--Not Available
Body temperature increased13.15.01.001--Not Available
Bovine tuberculosis11.04.01.0070.019111%Not Available
Bradycardia02.03.02.0020.019111%Not Available
C-reactive protein increased13.09.01.0070.025481%Not Available
Cachexia16.32.03.011; 14.03.02.001; 08.01.01.0090.003324%Not Available
Cardiac arrest02.03.04.0010.008309%
Cardio-respiratory arrest02.03.04.002; 22.02.06.0070.004985%Not Available
Cardiomegaly02.04.02.0010.003324%Not Available
Cerebellar ataxia08.01.02.006; 17.02.02.0130.012741%Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.0010.038222%
Cholestasis09.01.01.0010.009971%Not Available
Chromaturia20.02.01.0020.063703%
Coagulation factor decreased13.01.02.0160.012741%Not Available
Coagulopathy01.01.02.0010.019111%Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 12 Pages